Blagosklonny
Expert in non-small cell lung cancer treatment strategies
Best podcasts with Blagosklonny
Ranked by the Snipd community
Jun 6, 2024 • 8min
Dr. Blagosklonny’s Strategy: From Osimertinib to Preemptive Combinations
Dr. Blagosklonny, an expert in NSCLC treatment, discusses overcoming resistance in lung cancer therapy. He delves into the challenges with current EGFR inhibitors, the potential of Osimertinib as a third-generation TKI, and the use of preemptive combinations to enhance treatment outcomes.
